Oncology News

The FDA granted fast track designation to devimistat for the treatment of pancreatic cancer, according to the agent’s manufacturer.

A predictive model for advanced colorectal neoplasia may help increase colorectal cancer screening adherence, according to a study published in Gut.

Endoscopic resection was associated with similar cancer-specific survival compared with esophagectomy in patients with stage T1b esophageal adenocarcinoma, according to research presented at the ACG Virtual Annual Scientific Meeting.

Moving the age of first colorectal cancer screening to 45 years – even when recognizing real-world imperfect adherence – showed improved incidence and outcomes in a model presented at the American College of Gastroenterology annual meeting.

High incidence of malignant transformation in patients with pancreatic cysts confirms the need for close follow-up, according to a presentation at the American College of Gastroenterology Virtual Annual Scientific Meeting.

Scheduling a repeat colonoscopy the day after inadequate preparation may give a better chance for adequate prep and improve adenoma detection in a veteran population, according to research presented at the ACG Virtual Annual Scientific Meeting.

The incidence of anal cancer among women and those older than 50 years rose significantly from 2001 to 2016, according to a poster presented at the American College of Gastroenterology annual meeting.

In a lecture dedicated to her sister’s memory, Katie Couric engaged in an honest and raw conversation with ACG President Mark Pochapin, MD, about how her grief over her husband’s death and then her sister’s spurred Couric into action and advocacy.

The FDA granted priority review to fam-trastuzumab deruxtecan-nxki for treatment of HER2-positive metastatic gastric cancer or gastroesophageal junction adenocarcinoma.

All adults should begin to get screened for colorectal cancer at age 45 years, according to a draft recommendation by the U.S. Preventive Services Task Force.